1Rajakumar, K (2003) Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 112, E132–E135.
2Wolpowitz, D & Gilchrest, BA (2006) The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol 54, 301–317.
3Holick, MF (2007) Vitamin D deficiency. N Engl J Med 357, 266–281.
4Holick, MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 1678S–1688S.
5Zerwekh, JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87, 1087S–1091S.
6Nykjaer, A, Dragun, D, Walther, D, et al. . (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507–515.
7Al-oanzi, ZH, Tuck, SP, Raj, N, et al. . (2006) Assessment of vitamin D status in male osteoporosis. Clin Chem 52, 248–254.
8Binkley, N, Drezner, MK & Hollis, BW (2006) Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem 52, 2124–2125.
9Lissner, D, Mason, RS & Posen, S (1981) Stability of vitamin-D metabolites in human-blood serum and plasma. Clin Chem 27, 773–774.
10Antoniucci, DM, Black, DM & Sellmeyer, DE (2005) Serum 25-hydroxyvitamin D is unaffected by multiple freeze–thaw cycles. Clin Chem 51, 258–261.
11Carter, GD, Carter, R, Jones, J, et al. . (2004) How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50, 2195–2197.
12Binkley, N, Krueger, D, Cowgill, CS, et al. . (2004) Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89, 3152–3157.
13Glendenning, P, Taranto, M, Noble, JM, et al. . (2006) Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 43, 23–30.
14Terry, AH, Sandrock, T & Meikle, AW (2005) Measurement of 25-hydroxyvitamin D by the Nichols ADVANTAGE, DiaSorin LIAISON, DiaSorin RIA, and liquid chromatography–tandem mass spectrometry. Clin Chem 51, 1565–1566.
15Roth, HJ, Schmidt-Gayk, H, Weber, H, et al. . (2008) Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography–tandem mass spectrometry as a reference. Ann Clin Biochem 45, 153–159.
16Lensmeyer, GL, Wiebe, DA, Binkley, N, et al. . (2006) HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52, 1120–1126.
17Alvarez, JC & De Mazancourt, P (2001) Rapid and sensitive high-performance liquid chromatographic method for simultaneous determination of retinol, α-tocopherol, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human plasma with photodiode-array ultraviolet detection. J Chromatogr B Biomed Sci App 755, 129–135.
18Turpeinen, U, Hohenthal, U & Stenman, UH (2003) Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 49, 1521–1524.
19Olkowski, AA, Aranda-Osorio, G & McKinnon, J (2003) Rapid HPLC method for measurement of vitamin D3 and 25(OH)D3 in blood plasma. Int J Vitam Nutr Res 73, 15–18.
20Singh, RJ, Taylor, RL, Reddy, GS, et al. . (2006) C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 91, 3055–3061.
21Higashi, T, Awada, D & Shimada, K (2001) Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography–tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull 24, 738–743.
22Higashi, T, Shibayama, Y, Fuji, M, et al. . (2008) Liquid chromatography–tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal Bioanal Chem 391, 229–238.
23Aronov, PA, Hall, LM, Dettmer, K, et al. . (2008) Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 391, 1917–1930.
24Vogeser, M, Kyriatsoulis, A, Huber, E, et al. . (2004) Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography–tandem mass spectrometry. Clin Chem 50, 1415–1417.
25Tsugawa, N, Suhara, Y, Kamao, M, et al. . (2005) Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography–tandem mass spectrometry. Anal Chem 77, 3001–3007.
26Chen, HP, McCoy, LF, Schleicher, RL, et al. . (2008) Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography–tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 391, 6–12.
27Saenger, AK, Laha, TJ, Bremner, DE, et al. . (2006) Quantification of serum 25-hydroxyvitamin D2 and D3 using HPLC–tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 125, 914–920.
28Maunsell, Z, Wright, DJ & Rainbow, SJ (2005) Routine isotope-dilution liquid chromatography–tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51, 1683–1690.
29Capote, FP, Jimenez, JR, Granados, JMM, et al. . (2007) Identification and determination of fat-soluble vitamins and metabolites in human serum by liquid chromatography/triple quadrupole mass spectrometry with multiple reaction monitoring. Rapid Commun Mass Spectrom 21, 1745–1754.
30Grant, RP, Cameron, C & Mackenzie-McMurter, S (2002) Generic serial and parallel on-line direct-injection using turbulent flow liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 16, 1785–1792.
31Zimmer, D, Pickard, V, Czembor, W, et al. . (1999) Comparison of turbulent-flow chromatography with automated solid-phase extraction in 96-well plates and liquid–liquid extraction used as plasma sample preparation techniques for liquid chromatography–tandem mass spectrometry. J Chromatogr A 854, 23–35.
32Grant, WB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 92, 65–79.
33Heaney, RP (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 80, 1706S–1709S.
34Cherniack, EP, Florez, H, Roos, BA, et al. . (2008) Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 12, 366–373.
35Dawson-Hughes, B, Heaney, RP, Holick, MF, et al. . (2005) Estimates of optimal vitamin D status. Osteoporos Int 16, 713–716.
36Egan, KM, Signorello, LB, Munro, HM, et al. . (2008) Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control 19, 527–535.
37Mark, S, Gray-Donald, K, Delvin, EE, et al. . (2008) Low vitamin D status in a representative sample of youth from Quebec, Canada. Clin Chem 54, 1283–1289.
38Wolfenden, LL, Judd, SE, Shah, R, et al. . (2008) Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf) 69, 374–381.
39Mehrotra, R, Kermah, D, Budoff, M, et al. . (2008) Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 3, 1144–1151.
40Hedges, T & Scriven, A (2008) Sun safety: what are the health messages? J R Soc Promot Health 128, 164–169.
41Cranney, A, Weiler, HA, O'Donnell, S, et al. . (2008) Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88, 513S–519S.
42Vieth, R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69, 842–856.
44Maalouf, J, Nabulsi, M, Vieth, R, et al. . (2008) Short- and long-term safety of weekly high-dose vitamin D-3 supplementation in school children. J Clin Endocrinol Metab 93, 2693–2701.
45Heaney, RP, Armas, LAG, Shary, JR, et al. . (2008) 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87, 1738–1742.
47Ryan, PJ (2007) Vitamin D therapy in clinical practice. One dose does not fit all. Int J Clin Pract 61, 1894–1899.
48Gordon, CM, Williams, AL, Feldman, HA, et al. . (2008) Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 93, 2716–2721.
49Aloia, JF, Patel, M, DiMaano, R, et al. . (2008) Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 87, 1952–1958.
50Heaney, RP, Davies, KM, Chen, TC, et al. . (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204–210.
51Jones, G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88, 582S–586S.
52Armas, LAG, Hollis, BW & Heaney, RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89, 5387–5391.
53Trang, HM, Cole, DE, Rubin, LA, et al. . (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68, 854–858.
54Houghton, LA & Vieth, R (2006) The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84, 694–697.
55Leventis, P & Kiely, PDW (2009) The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 38, 149–153.
56Holick, MF, Biancuzzo, RM, Chen, TC, et al. . (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677–681.
57Melamed, ML, Michos, ED, Post, W, et al. . (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168, 1629–1637.
58Inaguma, D, Nagaya, H, Hara, K, et al. . (2008) Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 12, 126–131.
59Kovesdy, CP, Ahmadzadeh, S, Anderson, JE, et al. . (2008) Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168, 397–403.
60Patel, TV & Singh, AK (2008) Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease? Nat Clin Pract Endocrinol Metab 4, 484–485.
61Bischoff-Ferrari, HA, Willett, WC, Wong, JB, et al. . (2005) Fracture prevention with vitamin D supplementation – a meta-analysis of randomized controlled trials. JAMA 293, 2257–2264.
62Trivedi, DP, Doll, R & Khaw, KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. Br Med J 326, 469–472.
63Saquib, N, von Muhlen, D, Garland, CF, et al. . (2006) Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study. Osteoporos Int 17, 1734–1741.
64Michaelsson, K, Melhus, H, Bellocco, R, et al. . (2003) Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 32, 694–703.
65Roddam, AW, Neale, R, Appleby, P, et al. . (2007) Association between plasma 25-hydroxyvitamin D levels and fracture risk – The EPIC-Oxford study. Am J Epidemiol 166, 1327–1336.
66Zhu, K, Bruce, D, Austin, N, et al. . (2008) Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res 23, 1343–1348.
67Bischoff-Ferrari, HA, Dawson-Hughes, B, Willett, WC, et al. . (2004) Effect of vitamin D on falls – a meta-analysis. JAMA 291, 1999–2006.
68Gordon, PL, Sakkas, GK, Doyle, JW, et al. . (2007) Relationship between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr 17, 397–407.
69Suzuki, T, Kwon, J, Kim, H, et al. . (2008) Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J Bone Miner Res 23, 1309–1317.
70LeBoff, MS, Hawkes, WG, Glowacki, J, et al. . (2008) Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 19, 1283–1290.
71Bischoff-Ferrari, HA, Orav, EJ & Dawson-Hughes, B (2008) Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporos Int 19, 1307–1314.
72Adorini, L & Penna, G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4, 404–412.
73Ascherio, A & Munger, K (2008) Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 28, 17–28.
74Munger, KL, Levin, LI, Hollis, BW, et al. . (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832–2838.
75Freedman, DM, Dosemeci, H & Alavanja, MCR (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case–control study based on death certificates. Occup Environ Med 57, 418–421.
76Brown, SJ (2006) The role of vitamin D in multiple sclerosis. Ann Pharmacother 40, 1158–1161.
77Hypponen, E, Laara, E, Reunanen, A, et al. . (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500–1503.
78Dahlquist, G, Patterson, C, Soltesz, G, et al. . (1999) Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42, 51–54.
79Mohr, SB, Garland, CF, Gorham, ED, et al. . (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51, 1391–1398.
80Merlino, LA, Curtis, J, Mikuls, TR, et al. . (2004) Vitamin D intake is inversely associated with rheumatoid arthritis – results from the Iowa Women's Health Study. Arthritis Rheum 50, 72–77.
81Kamen, DL, Cooper, GS, Bouali, H, et al. . (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5, 114–117.
82Knekt, P, Laaksonen, M, Mattila, C, et al. . (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19, 666–671.
83Pittas, AG, Dawson-Hughes, B, Li, T, et al. . (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656.
84Mattila, C, Knekt, P, Maennistoe, S, et al. . (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30, 2569–2570.
85Zittermann, A, Schleithoff, SS & Koerfer, R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94, 483–492.
86Wang, L, Manson, JE, Buring, JE, et al. . (2008) Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51, 1073–1079.
87Forman, JP, Giovannucci, E, Holmes, MD, et al. . (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063–1069.
88Giovannucci, E, Liu, Y, Hollis, BW, et al. . (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men – a prospective study. Arch Intern Med 168, 1174–1180.
89Melamed, ML, Muntner, P, Michos, ED, et al. . (2008) Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease – results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28, 1179–1185.
90Dobnig, H, Pilz, S, Scharnagl, H, et al. . (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340–1349.
91Moe, SM (2007) Vitamin D cardiovascular disease, and survival in dialysis patients. J Bone Miner Res 22, V95–V99.
92Achinger, SG & Ayus, JC (2005) The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int 67, S37–S42.
93Shoji, T, Shinohara, K, Kimoto, E, et al. . (2004) Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19, 179–184.
94Wang, AYM, Lam, CWK, Sanderson, JE, et al. . (2008) Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 87, 1631–1638.
95Pilz, S, Dobnig, H, Fischer, JE, et al. . (2008) Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39, 2611–2613.
96Rajasree, S, Rajpal, K, Kartha, CC, et al. . (2001) Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 17, 567–571.
97Hsia, J, Heiss, G, Ren, H, et al. . (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115, 846–854.
98Michos, ED & Blumenthal, RS (2007) Vitamin D supplementation and cardiovascular disease risk. Circulation 115, 827–828.
99Lamprecht, SA & Lipkin, M (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3, 601–614.
100van der Rhee, HJ, de Vries, E & Coebergh, JWW (2006) Does sunlight prevent cancer? A systematic review. Eur J Cancer 42, 2222–2232.
101Kricker, A & Armstrong, B (2006) Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol 92, 132–139.
102Freedman, DM, Dosemeci, M & McGlynn, K (2002) Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case–control study. Occup Environ Med 59, 257–262.
103Grant, WB (2002) An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94, 1867–1875.
104Tuohimaa, P, Pukkala, E, Scelo, G, et al. . (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 43, 1701–1712.
105Giovannucci, E, Liu, Y, Rimm, EB, et al. . (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451–459.
106Ducloux, D, Courivaud, C, Bamoulid, J, et al. . (2008) Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 85, 1755–1759.
107Moan, J, Porojnicu, AC, Robsahm, TE, et al. . (2005) Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B Biol 78, 189–193.
108Zheng, W, Anderson, KE, Kushi, LH, et al. . (1998) A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 7, 221–225.
109Marcus, PM & Newcomb, PA (1998) The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int J Epidemiol 27, 788–793.
110Pritchard, RS, Baron, JA & deVerdier, MG (1996) Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 5, 897–900.
111McCullough, ML, Robertson, AS, Rodriguez, C, et al. . (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14, 1–12.
112Oh, K, Willett, WC, Wu, K, et al. . (2007) Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165, 1178–1186.
113Hartman, TJ, Albert, PS, Snyder, K, et al. . (2005) The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr 135, 252–259.
114Grau, MV, Baron, JA, Sandler, RS, et al. . (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95, 1765–1771.
115Kearney, J, Giovannucci, E, Rimm, EB, et al. . (1996) Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 143, 907–917.
116Kampman, E, Slattery, ML, Caan, B, et al. . (2000) Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11, 459–466.
117Terry, P, Baron, JA, Bergkvist, L, et al. . (2002) Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 43, 39–46.
118Lin, J, Zhang, SM, Cook, NR, et al. . (2005) Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol 161, 755–764.
119Kesse, E, Boutron-Ruault, MC, Norat, T, et al. . (2005) Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3N-EPIC prospective study. Int J Cancer 117, 137–144.
120Wactawski-Wende, J, Kotchen, JM, Anderson, GL, et al. . (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354, 684–696.
121Newmark, HL & Heaney, RP (2006) Calcium, vitamin D, and risk reduction of colorectal cancer. Nutr Cancer 56, 1–2.
122Levine, AJ, Harper, JM, Ervin, CM, et al. . (2001) Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 39, 35–41.
123Tangrea, J, Helzlsouer, K, Pietinen, P, et al. . (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8, 615–625.
124Peters, U, McGlynn, KA, Chatterjee, N, et al. . (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10, 1267–1274.
125Wu, K, Feskanich, D, Fuchs, CS, et al. . (2007) A nested case–control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99, 1120–1129.
126Otani, T, Iwasaki, M, Sasazuki, S, et al. . (2007) Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 97, 446–451.
127Gorham, ED, Garland, CF, Garland, FC, et al. . (2005) Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97, 179–194.
128Gorham, ED, Garland, CF, Garland, FC, et al. . (2007) Optimal vitamin D status for colorectal cancer prevention – a quantitative meta analysis. Am J Prev Med 32, 210–216.
129Cui, Y & Rohan, TE (2006) Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15, 1427–1437.
130Rohan, T (2007) Epidemiological studies of vitamin D and breast cancer. Nutr Rev 65, S80–S83.
131John, EM, Schwartz, GG, Dreon, DM, et al. . (1999) Vitamin D and breast cancer risk: The NHANES I Epidemiologic Follow-up Study, 1971–1975 to 1992. Cancer Epidemiol Biomarkers Prev 8, 399–406.
132Abbas, S, Linseisen, J & Chang-Claude, J (2007) Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case–control study. Nutr Cancer 59, 54–61.
133Shin, MH, Holmes, MD, Hankinson, SE, et al. . (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94, 1301–1311.
134Robien, K, Cutler, GJ & Lazovich, D (2007) Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control 18, 775–782.
135Knight, JA, Lesosky, M, Barnett, H, et al. . (2007) Vitamin D and reduced risk of breast cancer: a population-based case–control study. Cancer Epidemiol Biomarkers Prev 16, 422–429.
136Frazier, AL, Li, L, Cho, EY, et al. . (2004) Adolescent diet and risk of breast cancer. Cancer Causes Control 15, 73–82.
137Frazier, AL, Ryan, CT, Rockett, H, et al. . (2003) Adolescent diet and risk of breast cancer. Breast Cancer Res 5, R59–R64.
138McCullough, ML, Rodriguez, C, Diver, WR, et al. . (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 14, 2898–2904.
139Neuhouser, ML, Sorensen, B, Hollis, BW, et al. . (2008) Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 88, 133–139.
140Bertone-Johnson, ER, Chen, WY, Holick, MF, et al. . (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14, 1991–1997.
141Abbas, S, Linseisen, J, Slanger, T, et al. . (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer – results of a large case–control study. Carcinogenesis 29, 93–99.
142Freedman, DM, Chang, SC, Falk, RT, et al. . (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17, 889–894.
143Hughes, AM, Armstrong, BK, Vajdic, CM, et al. . (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case–control study. Int J Cancer 112, 865–871.
144Smedby, KE, Hjalgrim, H, Melbye, M, et al. . (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97, 199–209.
145Hartge, P, Lim, U, Freedman, DM, et al. . (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17, 1045–1052.
146Weihkopf, T, Becker, N, Nieters, A, et al. . (2007) Sun exposure and malignant lymphoma: a population-based case–control study in Germany. Int J Cancer 120, 2445–2451.
147Soni, LK, Hou, LF, Gapstur, SM, et al. . (2007) Sun exposure and non-Hodgkin lymphoma: a population-based, case–control study. Eur J Cancer 43, 2388–2395.
148Kricker, A, Armstrong, BK, Hughes, AM, et al. . (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122, 144–154.
149Polesel, J, Talamini, R, Montella, M, et al. . (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17, 713–718.
150John, EM, Dreon, DM, Koo, J, et al. . (2004) Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol 89–90, 549–552.
151Colli, JL & Grant, WB (2008) Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States. Urology 71, 531–535.
152Grant, WB (2004) Geographic variation of prostate cancer mortality rates in the United States: implications for prostate cancer risk related to vitamin D. Int J Cancer 111, 470–471.
153Chan, JM, Giovannucci, E, Andersson, SO, et al. . (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9, 559–566.
154Kristal, AR, Cohen, JH, Qu, PP, et al. . (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11, 719–725.
155Tseng, M, Breslow, RA, Graubard, BI, et al. . (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81, 1147–1154.
156Tavani, A, Bertuccio, P, Bosetti, C, et al. . (2005) Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. Eur Urol 48, 27–33.
157Park, SY, Murphy, SP, Wilkens, LR, et al. . (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk – The Multiethnic Cohort Study. Am J Epidemiol 166, 1259–1269.
158Huncharek, M, Muscat, J & Kupelnick, B (2008) Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26 769 cases from 45 observational studies. Nutr Cancer 60, 421–441.
159Gann, PH, Ma, J, Hennekens, CH, et al. . (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5, 121–126.
160Nomura, AMY, Stemmermann, GN, Lee, J, et al. . (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 9, 425–432.
161Platz, EA, Leitzmann, MF, Hollis, BW, et al. . (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15, 255–265.
162Jacobs, ET, Giuliano, AR, Martinez, EM, et al. . (2004) Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89–90, 533–537.
163Ahn, J, Peters, U, Albanes, D, et al. . (2008) Serum vitamin D concentration and prostate cancer risk: a nested case–control study. J Natl Cancer Inst 100, 796–804.
164Ahonen, MH, Tenkanen, L, Teppo, L, et al. . (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11, 847–852.
165Tuohimaa, P, Tenkanen, L, Ahonen, M, et al. . (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countries. Int J Cancer 108, 104–108.
166Tuohimaa, P, Tenkanen, L, Syvala, H, et al. . (2007) Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16, 302–307.
167Li, HJ, Stampfer, MJ, Hollis, JBW, et al. . (2007) A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 4, 562–571.
168Lefkowitz, ES & Garland, CF (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23, 1133–1136.
169Garland, CF, Mohr, SB, Gorham, ED, et al. . (2006) Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 31, 512–514.
170Salazar-Martinez, E, Lazcano-Ponce, EC, Lira-Lira, GG, et al. . (2002) Nutritional determinants of epithelial ovarian cancer risk: a case–control study in Mexico. Oncology 63, 151–157.
171Bidoli, E, La Vecchia, C, Talamini, R, et al. . (2001) Micronutrients and ovarian cancer: a case–control study in Italy. Ann Oncol 12, 1589–1593.
172Goodman, MT, Wu, AH, Tung, KH, et al. . (2002) Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156, 148–157.
173Koralek, DO, Bertone-Johnson, ER, Leitzmann, MF, et al. . (2006) Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 56, 22–30.
174Genkinger, JM, Hunter, DJ, Spiegelman, D, et al. . (2006) Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15, 364–372.
175Tworoger, SS, Lee, IM, Buring, JE, et al. . (2007) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 16, 783–788.
176Skinner, HG, Michaud, DS, Giovannucci, E, et al. . (2006) Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 15, 1688–1695.
177Stolzenberg-Solomon, RZ, Vieth, R, Azad, A, et al. . (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66, 10213–10219.
178Michaud, DS (2006) Vitamin D and pancreatic cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention cohort. Cancer Res 66, 9802–9803.
179Bidoli, E, Bosetti, C, La Vecchia, C, et al. . (2003) Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case–control study. Cancer Causes Control 14, 477–484.
180Chen, W, Dawsey, SM, Qiao, YL, et al. . (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97, 123–128.
181Badros, A, Goloubeva, O, Terpos, E, et al. . (2008) Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 142, 492–494.
182Mohr, SB, Gorham, ED, Garland, CF, et al. . (2006) Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer 119, 2705–2709.
183McCullough, ML, Bandera, EV, Moore, DF, et al. . (2008) Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med 46, 298–302.
184Rosso, S, Sera, F, Segnan, N, et al. . (2008) Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients. Eur J Cancer 44, 1275–1281.